ResearcherActive in the last 2 years

Yuming Zhang

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0009-0007-9710-7726; OpenAlex author ID A5115590788.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis. First author DOI 10.1007/s10620-024-08715-z ↗
The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of … Co-author DOI 10.2147/cmar.s349442 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Na Zhou · 1 shared paper, 2025
- Paper CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis. DOI 10.1007/s10620-024-08715-z ↗
Xiaochun Zhang · 1 shared paper, 2022
- Paper The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gem… DOI 10.2147/cmar.s349442 ↗
Feng Zhang · 1 shared paper, 2022
- Paper The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gem… DOI 10.2147/cmar.s349442 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.